INFLAMMATORY HYPERTROPHIC CAUDA EQUINA SYNDROME FOLLOWING INTRATHECAL NEURAL STEM CELL INJECTION

摘要

The potential benefit for stem cell therapy to repair, restore, replace, and regenerate damaged tissues has many patients with chronic neurological conditions excited about possible treatments. Research in this area continues to grow throughout the world. The U.S. National Institute of Health reports over 45 registered trials world-wide that relate to stem cell therapy and spinal cord injury alone.1 There is no way to know how" many unregistered and uncontrolled treatments are offered in "notorious" stem cell clinics for chronic conditions that range from rejuvenation to cerebral palsy, stroke, Parkinson disease, traumatic brain and spinal cord injury, multiple sclerosis, and amyotrophic lateral sclerosis. ~ Along with increased research, more and more patients are seeking stem cell therapy before the safety and efficacy of such treatments have been established. Some experts have concerns that the hope and expectations, patients have for cures cannot be met. This may leave patients vulnerable to nonre-gulated providers of stem cell treatments that are potentially harmful.